The launch of Fluticasone/Salmeterol combination inhaler, a generic version of GSK’s Advair MDI (metered dose inhaler), by pharmaceutical major Cipla in Germany and Sweden is seen as a significant ... Read More
We use cookies to improve your browsing experience on our website. To find out more, please read our Privacy Policy and Cookies Policy, been updated and became effective May 24, 2018.
By continuing to navigate our website without changing your cookies settings, or by clicking 'Ok', you hereby acknowledge and agree to OneStopBrokers use of cookies.OkRead more